Video on Protein-protein interactions

Watch this exciting video to learn more about our poster on ‘Screening for inhibitors of protein: protein interactions in living cells: Development of assays to detect modulation of proteins using NanoBRET  technology’: http://bit.ly/2KervD2.  Follow the...

Vacancy: Graduate Biologist

AURELIA BIOSCIENCE is a small contract research organisation based at Biocity in Nottingham. We provide cell- and biochemical-based assay development and compound screening in microwell plates with innovative assay formats and readouts. Working collaboratively with a...

Video: International Women’s Day 2019

As we celebrate International Women’s Day across the world today, here’s a short video featuring Aurelia Bioscience’s Science Director, Kathy Dodgson. Not only is Kathy a remarkable scientist, having led the development and implementation of various new screening...

Research in Oncology: The fight continues

Cancer is a group of multifactorial diseases with complex genesis and progression. Irrespective of the type, all tumour cells are characterised by their ability to grow, invade and metastasise in an unregulated manner. According to statistics, around 9.6 million...

Synergy between CROs and their client partners

As innovations in drug discovery continue to abound, the relationship between pharmaceutical/ biotechnology industry and CROs (Contract Research Organisations) has strengthened significantly. However, choosing the right CRO for a project is not always straightforward....

New service launch!

Aurelia Bioscience now offers kinase compound profiling services using Promega’s NanoBRET™ Target Engagement (TE) Intracellular Kinase Assays: http://bit.ly/2BVzzo0 Are you looking to screen your compounds against specific kinase targets? Get in touch with our...